These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 32612950)
1. Immunomodulation of NK Cells by Ionizing Radiation. Chen J; Liu X; Zeng Z; Li J; Luo Y; Sun W; Gong Y; Zhang J; Wu Q; Xie C Front Oncol; 2020; 10():874. PubMed ID: 32612950 [TBL] [Abstract][Full Text] [Related]
2. Low-dose ionizing radiation induces direct activation of natural killer cells and provides a novel approach for adoptive cellular immunotherapy. Yang G; Kong Q; Wang G; Jin H; Zhou L; Yu D; Niu C; Han W; Li W; Cui J Cancer Biother Radiopharm; 2014 Dec; 29(10):428-34. PubMed ID: 25402754 [TBL] [Abstract][Full Text] [Related]
3. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104. Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142 [TBL] [Abstract][Full Text] [Related]
5. Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors. Poggi A; Massaro AM; Negrini S; Contini P; Zocchi MR J Immunol; 2005 Mar; 174(5):2653-60. PubMed ID: 15728472 [TBL] [Abstract][Full Text] [Related]
6. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity. Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759 [TBL] [Abstract][Full Text] [Related]
7. Gene transfer of the CD40-ligand to human dendritic cells induces NK-mediated antitumor effects against human carcinoma cells. Tomihara K; Kato K; Masuta Y; Nakamura K; Tanaka T; Hiratsuka H; Hamada H Int J Cancer; 2007 Apr; 120(7):1491-8. PubMed ID: 17205529 [TBL] [Abstract][Full Text] [Related]
8. Selenium-containing ruthenium complex synergizes with natural killer cells to enhance immunotherapy against prostate cancer via activating TRAIL/FasL signaling. Lai H; Zeng D; Liu C; Zhang Q; Wang X; Chen T Biomaterials; 2019 Oct; 219():119377. PubMed ID: 31374478 [TBL] [Abstract][Full Text] [Related]
9. The ischemia-responsive protein 94 (Irp94) activates dendritic cells through NK cell receptor protein-2/NK group 2 member D (NKR-P2/NKG2D) leading to their maturation. Srivastava RM; Varalakshmi C; Khar A J Immunol; 2008 Jan; 180(2):1117-30. PubMed ID: 18178852 [TBL] [Abstract][Full Text] [Related]
10. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. Kayagaki N; Yamaguchi N; Nakayama M; Takeda K; Akiba H; Tsutsui H; Okamura H; Nakanishi K; Okumura K; Yagita H J Immunol; 1999 Aug; 163(4):1906-13. PubMed ID: 10438925 [TBL] [Abstract][Full Text] [Related]
11. Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells. Kajitani K; Tanaka Y; Arihiro K; Kataoka T; Ohdan H Breast Cancer Res Treat; 2012 Jul; 134(1):139-55. PubMed ID: 22261932 [TBL] [Abstract][Full Text] [Related]
12. Natural killer group 2D receptor and its ligands in cancer immune escape. Duan S; Guo W; Xu Z; He Y; Liang C; Mo Y; Wang Y; Xiong F; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W; Wang F Mol Cancer; 2019 Feb; 18(1):29. PubMed ID: 30813924 [TBL] [Abstract][Full Text] [Related]
14. Sequential radiation exposure: uncovering the potential of low dose ionizing radiation in mitigating high dose effects on immune cells. Masoudi S; Kalani M; Alavianmehr A; Mosleh-Shirazi MA; Mortazavi SMJ; Farjadian S Int J Radiat Biol; 2024; 100(7):1009-1018. PubMed ID: 38776451 [TBL] [Abstract][Full Text] [Related]
15. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology. Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457 [TBL] [Abstract][Full Text] [Related]
16. The proteasome inhibitor bortezomib disrupts tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression and natural killer (NK) cell killing of TRAIL receptor-positive multiple myeloma cells. Feng X; Yan J; Wang Y; Zierath JR; Nordenskjöld M; Henter JI; Fadeel B; Zheng C Mol Immunol; 2010 Aug; 47(14):2388-96. PubMed ID: 20542572 [TBL] [Abstract][Full Text] [Related]
17. Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHT. Holmes TD; Wilson EB; Black EV; Benest AV; Vaz C; Tan B; Tanavde VM; Cook GP Proc Natl Acad Sci U S A; 2014 Dec; 111(52):E5688-96. PubMed ID: 25512551 [TBL] [Abstract][Full Text] [Related]
18. Shaping of Natural Killer Cell Antitumor Activity by Granzin M; Wagner J; Köhl U; Cerwenka A; Huppert V; Ullrich E Front Immunol; 2017; 8():458. PubMed ID: 28491060 [TBL] [Abstract][Full Text] [Related]
19. The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression. Ghiringhelli F; Ménard C; Martin F; Zitvogel L Immunol Rev; 2006 Dec; 214():229-38. PubMed ID: 17100888 [TBL] [Abstract][Full Text] [Related]
20. Transcriptome analysis of low-dose ionizing radiation-impacted genes in CD4 Cho SJ; Kang H; Hong EH; Kim JY; Nam SY J Immunotoxicol; 2018 Dec; 15(1):137-146. PubMed ID: 30686136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]